Best Vagus Nerve Devices: Nurosym vs Truvaga vs Apollo

You can stimulate the vagus nerve four ways with a consumer device: ear-clip, handheld at the neck, wrist/ankle vibration, or a band worn around the neck. Each works differently. Each has different evidence behind it.

If you want the strongest research base and you're serious about a daily protocol — Nurosym.

If you want FDA clearance (specifically for migraine, but useful as a vagal tool generally) — Truvaga.

If you want passive wearable mood support, not direct nervous system intervention — Apollo Neuro.

If you're curious about a newer category and willing to try less-validated tech — Pulsetto.

Here's the honest version, with what each one actually does, what the research shows, and which one I personally use.

Before comparing devices, a baseline: not everything called "vagus nerve stimulation" is the same thing.

The vagus nerve is the main highway of your parasympathetic nervous system. It runs from your brainstem through your neck and into nearly every organ. You can activate it in three ways:

1. Electrical stimulation of accessible branches (auricular branch in the ear, cervical branch in the neck)
2. Vibration / mechanical stimulation that may have weaker but related effects
3. Behavioral (humming, cold water on face, slow breathing) — works but slow

Most of the research on transcutaneous vagus nerve stimulation (tVNS) uses category 1 — direct electrical pulses to the ear or neck. That's what the strongest evidence base supports.¹

Devices in this comparison span all three categories. They're not equivalent. They produce different effects on the autonomic nervous system, and on HRV measurably so.

Best for: daily clinical-grade vagal stimulation backed by meaningful research. What I use.

The Nurosym is an ear-clip that connects to a small handheld unit. You clip it to the cymba conchae of your ear (the area near the canal where the auricular branch of the vagus nerve is accessible). Sessions are typically 30-60 minutes. Sensation is a mild tingling.

What it does well:

• Strong research base. Built by Parasym, the UK medical device company behind multiple peer-reviewed tVNS studies on HRV, inflammation, and cognitive outcomes.²
• Direct vagal activation. Targets the auricular branch directly — the same anatomy used in clinical research.
• Daily-use friendly. Hands-free during reading, work, sleep onset. I wear it during morning coffee + work.
• Adjustable intensity. Find your threshold; stay just below sensation pain.
• Real HRV response. My Whoop trend climbing from 35 to ~50ms tracks with daily Nurosym use through the protocol.

What Nurosym gets wrong:

• Cost — ~$600+ for the device. Cheaper than research-grade equipment, expensive vs. an app.
• Ear-clip can be uncomfortable for extended sessions until you adjust the position.
• Only one ear at a time. You can stim either ear (the published trials show roughly equivalent effect), but not both simultaneously with a standard kit.
• Visible. You're not wearing this in a meeting.

Why I use it: the research is the closest to clinical-grade of any consumer device on this list, and the daily use fits into existing routines. The cost is real but per-hour-of-protocol, it's by far the lowest of the four.

Best for: people who want FDA-cleared vagal stimulation, especially with migraine history.

Truvaga is the consumer brand. gammaCore is the same underlying technology, sold as an FDA-cleared medical device for cluster headache, migraine, and certain post-stroke indications. Made by Electrocore — the only consumer device on this list with FDA clearance for any condition.

Hardware: a handheld device you press against the side of your neck (over the cervical branch of the vagus nerve) for 2-minute sessions, 2-4x daily. Electrical pulse pattern is different from ear-clip tVNS.

What it does well:

• FDA clearance (gammaCore for migraine; Truvaga as wellness-grade). The most regulatory-validated of these devices.
• Quick sessions — 2 minutes, not 30. Different use pattern from Nurosym.
• Clinical research base — Electrocore has dozens of published studies, mostly in the migraine/headache space but useful for vagal mechanism generally.³
• Targets cervical vagus — accessing a different branch than ear-clip devices.

What it gets wrong:

• Subscription model (Truvaga) — ~$1000+ over the first year, depending on tier
• Short sessions don't build sustained activation the way 30-min daily Nurosym sessions do
• Hands-required — you have to hold it in place, so you can't multitask the way ear-clip allows
• Research is mostly in clinical conditions (migraine), less in healthy-adult HRV optimization

Who should pick Truvaga: people with migraine history or chronic headache who want the dual purpose. People who prefer short, intense, scheduled sessions to background passive use. People who want FDA clearance specifically.

Best for: passive mood support. NOT the same category as electrical vagal stimulation.

Apollo Neuro is a wrist or ankle wearable that delivers vibration patterns — not electrical stimulation. The company describes it as "vibrational vagal stimulation." Founded by neuroscientist David Rabin (MD/PhD), backed by university research at University of Pittsburgh.

How it works: low-frequency vibrations on the wrist or ankle (via mechanoreceptors in the skin) that the developers argue affect autonomic state. It's a different mechanism from tVNS — closer to grounded sensory input than direct nerve stimulation.

What it does well:

• Passive wear. Set a mode (energy, calm, focus, sleep), forget about it.
• University research base — Pittsburgh and others have published on it.⁴
• Subjectively pleasant — users often report a sense of calm during sleep mode.
• Solid build quality, water-resistant

What Apollo Neuro gets wrong:

• Mechanism is fundamentally different from tVNS. The HRV evidence is much weaker than electrical vagal devices.
• Subjective effects > objective effects. The Apollo Neuro trials report meaningful subjective improvement but smaller HRV/biomarker shifts.
• Cost is substantial for a vibration wearable (~$350)
• Doesn't replace direct vagal stimulation for someone running a serious nervous system protocol

Who should pick Apollo Neuro: people who want a passive wellness wearable they don't have to actively use. People who specifically respond to vibration/sensory input. People who already have a Nurosym/Truvaga + want supplementary mood support.

What it's NOT: a substitute for electrical tVNS in any clinical or research context. If your goal is to measurably move HRV via vagal activation, Apollo Neuro alone won't do that as effectively as Nurosym would.

Best for: people curious about the new category, willing to be earlier-adopter.

Pulsetto is a neck-mounted tVNS device — sits behind the ears, delivers electrical pulses to the cervical branch of the vagus nerve. Newer brand, launched 2023. Has been marketed aggressively in the longevity space.

What it does:

• Hands-free like Nurosym, but neck-mounted
• Multiple programs for stress, sleep, focus
• Cheaper than Nurosym (~$300 with subscription)

What Pulsetto gets wrong:

• Less validated research base. The studies that exist are mostly company-funded or pilot-scale. Independent peer-reviewed validation is limited.
• Specific electrode design may be less optimal than ear-clip approaches (this is debated in the tVNS literature)
• Subscription model for the full feature set
• No FDA clearance of any tier

Who should pick Pulsetto: people who want to try tVNS at a lower price point and are willing to accept less-validated research. Not the device to pick if you want maximum confidence in mechanism.

If you're going to buy one vagal device for a longevity protocol: Nurosym. Strongest research base, daily-use friendly, the device that most reliably moves HRV. What I wear daily through the protocol.

If you have migraine history or want FDA clearance specifically: Truvaga (or gammaCore via prescription). Same underlying tech, different format, dual-purpose if migraines are an issue.

If you want passive mood support layered on top of a direct vagal device: Apollo Neuro as a secondary. Don't make it your primary intervention.

If you're price-constrained and willing to be an early adopter: Pulsetto is the lowest-cost entry point. Just understand the research base is less mature.

I don't have a current affiliate relationship with Nurosym (Cat has her own personal referral link separate from KINS — coming when she sets it up). KINS doesn't have an exclusive vagal-device partnership yet — that decision is still open.

Honest limits:

• None of them replace sleep. A vagal device won't fix a body that's sleep-deprived. Sleep architecture is upstream of everything.
• None of them treat trauma or PTSD alone. They can be useful adjunctive to therapy; they don't replace it.
• None of them work without consistency. Daily use for 4-8 weeks is the protocol. 3 sessions in a row then 2 weeks off doesn't move the needle.
• None of them produce instant results. Acute HRV response during a session, yes. Sustained shift requires weeks.
• All of them work better stacked with breathing work + cold + sleep. The protocol is multi-pronged.

If you're running a full nervous system protocol (see: How to reset your nervous system), a vagal device is one of four interventions, not the whole answer.

How long until I notice a difference with Nurosym?
Subjective effect during the first session (slight calm, sometimes lightheadedness — adjust intensity). Measurable HRV trend shift in 2-4 weeks of daily use.

Can I sleep with Nurosym on?
Yes — the device automatically times out. Some people use it for sleep onset specifically.

Is gammaCore the same as Truvaga?
Same underlying technology. gammaCore is the FDA-cleared prescription medical device. Truvaga is the consumer wellness version sold without prescription.

Does Apollo Neuro actually activate the vagus nerve?
Debated. The mechanism is different from electrical tVNS. Subjective effects are real for many users. Objective HRV / biomarker shifts are smaller than with electrical devices.

Can I use a vagal device with a pacemaker?
No — most contraindicate cardiac implants. Always check with the manufacturer and your cardiologist before use.

What if I have implanted neurostimulators (DBS, spinal stim)?
Same — check with your specialist first.

Will my insurance cover any of these?
gammaCore for migraine: sometimes, with prescription. Consumer wellness versions: no.

This is the honest version. Nurosym is what I use because the research base + daily-protocol fit is strongest for what I'm trying to do. Other people have different goals — Truvaga for migraine, Apollo Neuro for passive mood support, Pulsetto for budget. Pick based on your actual use case.

KINS doesn't yet have an exclusive vagal-device partnership. When we do, we'll publish the reasoning openly — including any commercial relationship. Until then, this comparison reflects only the data and my own protocol.

— Cathy

Up next:

How to reset your nervous system — the full 4-intervention protocol that uses vagal stimulation as one component.

What is HRV? — the metric these devices are designed to move.

The 14-Day Deep Reset →

1. Yuan H, Silberstein SD (2016). Vagus nerve and vagus nerve stimulation, a comprehensive review: part II. Headache: The Journal of Head and Face Pain, 56(2), 259-266. PubMed
2. Mertens A, et al. (2018). Transcutaneous vagus nerve stimulation does not affect verbal memory performance in healthy volunteers. Frontiers in Psychology, 9, 1276. PubMed
3. Silberstein SD, et al. (2016). Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study. Headache, 56(8), 1317-1332. PubMed
4. Rabin BS, et al. (2018). The use of vibroacoustic therapy to reduce experimentally induced stress and improve performance. Frontiers in Psychology, 9, 1306. PubMed
5. Capilupi MJ, et al. (2020). Vagus nerve stimulation and the cardiovascular system. Cold Spring Harbor Perspectives in Medicine, 10(2). PubMed
6. Kraemer KM, et al. (2022). Vagus nerve stimulation as a potential adjunctive treatment for COVID-19. Frontiers in Medicine, 9, 855662. PubMed